《Clinical Science》雜志的最新年發文量為103篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在醫學：研究與實驗領域的學術影響力。
該刊聚焦于醫學-醫學：研究與實驗領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 偏慢,4-8周 。
Clinical Science 雜志發文統計
文章名稱引用次數
- Atherosclerosis and inflammation: overview and updates100
- Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure55
- Hsa_circ_0009361 acts as the sponge of miR-582 to suppress colorectal cancer progression by regulating APC2 expression29
- A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes27
- CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway25
- MicroRNAs and other non-coding RNAs in adipose tissue and obesity: emerging roles as biomarkers and therapeutic targets24
- Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins24
- SGLT2 inhibition and kidney protection23
- Implications of plasma thiol redox in disease21
- CircRASSF2 promotes laryngeal squamous cell carcinoma progression by regulating the miR-302b-3p/IGF-1R axis20
國家/地區發文量
- CHINA MAINLAND174
- USA160
- Australia61
- Canada33
- Brazil31
- Scotland30
- England29
- Italy26
- GERMANY (FED REP GER)21
- Japan18
